The city of Munich is set to play host to the 11th annual Clinical Trials in Oncology Europe 2024 conference where speakers, sponsors and guests from across the continent and beyond will converge at the Sofitel Munich Bayerpost for two days of presentations and talks.
The two-day conference will see speakers covering a myriad of subjects ranging from artificial intelligence (AI) strategy, regulations, and patient feedback. Among speakers from GlobalData’s clinical trials analytics teams, the event will play host to guests from sponsors and clinical research organisations including companies such as Sandoz and Blue Earth Therapeutics.
Among some of the day one highlights on the agenda, Frank Richard vice president of Heidelburg will take to the stage for the first talk of the conference entitled: “Establishing an AI strategy for oncology clinical trials”.
At the Outsourcing in Clinical Trials New England Conference in Boston in October, experts in the field suggested operations could be stabilised by utilising approaches with AI in tasks such as trial recruitment. Richard’s talk is set to focus on what pharmaceutical firms need to consider when choosing to adopt the technology.
Later in the first day, the main stage will host a panel discussion about reducing the imaging burden on patients. There will be speakers from Medidata and Dassault Systèmes as well as a patient advocate to discuss how patients understand imaging systems plus some do’s and do not’s when handling their data. Exacerbated by a worldwide shortage of imaging specialists such as radiologists, the imaging and scanning process in trials can present a number of hurdles for patients, usually requiring them to make multiple trips to specialists. As a result, a number of technology firms, such as NVIDIA, are trying to break into the space to smooth out the process.
Along the same theme, the morning of day two will include a talk presented by a senior solutions consultant for US trial technology company Suvoda, Daniela Duffet, on streamlining clinical processes for the benefit of patients. The session will identifying stressors for patients and look at technological solutions aimed at reducing workloads across sites. It follows after Suvoda launched its own purpose-built software platform designed to provide a seamless way for drug trial sponsors and sites to manage data across sites.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataLater on the final day COO of Node Pharma, Helen Johansen, will break down business matters in her talk “What is needed to build a major biotechnology/pharmaceutical company: an evaluation of the level of ambition and the possible underlying causes”. The years following the Covid-19 pandemic have been tumultuous for the life sciences sector with job cuts alongside mergers and acquisitions marking the industry indelibly. In her talk, Johansen is going to break down management techniques and barriers holding some businesses back.
The 11th annual Clinical Trials in Oncology Europe conference is set to run on December 3 and 4. Information and registration can be found on the Arena International website.
